Leslie Thomas
Family · Columbus, OHNPI 1164616421
Payments from drug & device makers
Across 150 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$480
- Johnson & Johnson$419
- Teva Pharmaceuticals USA, Inc.$389
- Alkermes, Inc.$350
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$289
- Indivior Inc.$227
- plus $618 from 8 others
What the payments were for
- Food & beverage$2,48790%
- Education$28510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $480 |
| Johnson & Johnson | 20 | $419 |
| Teva Pharmaceuticals USA, Inc. | 24 | $389 |
| Alkermes, Inc. | 18 | $350 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $289 |
| Indivior Inc. | 14 | $227 |
| Otsuka America Pharmaceutical, Inc. | 11 | $198 |
| Neurocrine Biosciences, Inc. | 6 | $130 |
| Lundbeck LLC | 5 | $101 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Bausch Health US, LLC | 1 | $13 |
How this compares
$2,772 in reported general payments places this provider in the 85th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 97 | $305,484 |
| Invega TrinzaPaliperidone Palmitate | 28 | $247,598 |
| IngrezzaValbenazine Tosylate | 25 | $189,256 |
| Abilify MaintenaAripiprazole | 64 | $146,168 |
| CaplytaLumateperone Tosylate | 72 | $131,524 |
| RexultiBrexpiprazole | 64 | $95,847 |
| UzedyRisperidone | 28 | $91,528 |
| VraylarCariprazine Hcl | 55 | $78,126 |
| PerserisRisperidone | 25 | $75,065 |
| Lurasidone Hcl | 142 | $50,445 |
| Risperdal ConstaRisperidone Microspheres | 19 | $39,647 |
| FanaptIloperidone | 12 | $27,362 |
| Aripiprazole | 193 | $21,211 |
| FetzimaLevomilnacipran Hcl | 42 | $20,057 |
| TrintellixVortioxetine Hydrobromide | 27 | $12,994 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta | $419 | $592,729144 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $198 | $242,015128 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $130 | $189,25625 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $289 | $131,52472 claims |
| AbbVieVraylar, Fetzima | $480 | $98,18397 claims |
| Teva Pharmaceuticals USA, Inc.Uzedy | $389 | $91,52828 claims |
| Indivior Inc.Perseris | $227 | $75,06525 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $70 | $27,36212 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $28 | $12,99427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,812 family providers in Ohio.
Other family in Columbus
- Christina GastColumbus$66K
- Beth LoessinColumbus$34K
- Mary HurleyColumbus$15K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.